Literature DB >> 23194048

Causes of death of patients with lung cancer.

Larry Nichols1, Rachel Saunders, Friedrich D Knollmann.   

Abstract

CONTEXT: The causes of death for patients with lung cancer are inadequately described.
OBJECTIVE: To categorize the immediate and contributing causes of death for patients with lung cancer.
DESIGN: The autopsies from 100 patients who died of lung cancer between 1990 and February 2011 were analyzed.
RESULTS: Tumor burden was judged the immediate cause of death in 30 cases, including 26 cases of extensive metastases and 4 cases with wholly or primarily lung tumor burden (causing respiratory failure). Infection was the immediate cause of death for 20 patients, including 8 with sepsis and 12 with pneumonia. Complications of metastatic disease were the immediate causes of death in 18 cases, including 6 cases of hemopericardium from pericardial metastases, 3 from myocardial metastases, 3 from liver metastases, and 3 from brain metastases. Other immediate causes of death were pulmonary hemorrhage (12 cases), pulmonary embolism (10 cases, 2 tumor emboli), and pulmonary diffuse alveolar damage (7 cases). From a functional (pathophysiologic) perspective, respiratory failure could be regarded as the immediate cause of death (or mechanism of death) in 38 cases, usually because of a combination of lung conditions, including emphysema, airway obstruction, pneumonia, hemorrhage, embolism, resection, and lung injury in addition to the tumor. For 94 of the 100 patients, there were contributing causes of death, with an average of 2.5 contributing causes and up to 6 contributing causes of death.
CONCLUSIONS: The numerous and complex ways lung cancer kills patients pose a challenge for efforts to extend and improve their lives.

Entities:  

Mesh:

Year:  2012        PMID: 23194048     DOI: 10.5858/arpa.2011-0521-OA

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN: 0003-9985            Impact factor:   5.534


  46 in total

1.  Synthesis and in vitro antitumor activity of (1E,4E)-1-aryl-5-(2-((quinazolin-4-yl)oxy)phenyl)-1,4-pentadien-3-one derivatives.

Authors:  Hui Luo; Shengjie Yang; Da Hong; Wei Xue; Pu Xie
Journal:  Chem Cent J       Date:  2017-03-15       Impact factor: 4.215

2.  Dichloroacetate should be considered with platinum-based chemotherapy in hypoxic tumors rather than as a single agent in advanced non-small cell lung cancer.

Authors:  Edward B Garon; Heather R Christofk; Wylie Hosmer; Carolyn D Britten; Agnes Bahng; Matthew J Crabtree; Candice Sun Hong; Naeimeh Kamranpour; Sharon Pitts; Fairooz Kabbinavar; Cecil Patel; Erika von Euw; Alexander Black; Evangelos D Michelakis; Steven M Dubinett; Dennis J Slamon
Journal:  J Cancer Res Clin Oncol       Date:  2014-01-18       Impact factor: 4.553

Review 3.  Palliative Care in Lung Cancer: When to Start.

Authors:  Prianka Bhattacharya; Scott K Dessain; Tracey L Evans
Journal:  Curr Oncol Rep       Date:  2018-11-09       Impact factor: 5.075

4.  Frequency of brain metastases in non-small-cell lung cancer, and their association with epidermal growth factor receptor mutations.

Authors:  Toshihiko Iuchi; Masato Shingyoji; Meiji Itakura; Sana Yokoi; Yasumitsu Moriya; Hajime Tamura; Yasushi Yoshida; Hironori Ashinuma; Koichiro Kawasaki; Yuzo Hasegawa; Tsukasa Sakaida; Toshihiko Iizasa
Journal:  Int J Clin Oncol       Date:  2014-10-22       Impact factor: 3.402

5.  The Effect of Gene Alterations and Tyrosine Kinase Inhibition on Survival and Cause of Death in Patients With Adenocarcinoma of the Lung and Brain Metastases.

Authors:  Paul W Sperduto; T Jonathan Yang; Kathryn Beal; Hubert Pan; Paul D Brown; Ananta Bangdiwala; Ryan Shanley; Norman Yeh; Laurie E Gaspar; Steve Braunstein; Penny Sneed; John Boyle; John P Kirkpatrick; Kimberley S Mak; Helen A Shih; Alex Engelman; David Roberge; Nils D Arvold; Brian Alexander; Mark M Awad; Joseph Contessa; Veronica Chiang; John Hardie; Daniel Ma; Emil Lou; William Sperduto; Minesh P Mehta
Journal:  Int J Radiat Oncol Biol Phys       Date:  2016-06-14       Impact factor: 7.038

6.  Analysis of gastrointestinal metastasis of primary lung cancer: Clinical characteristics and prognosis.

Authors:  Naohiro Taira; Tsutomu Kawabata; Atsushi Gabe; Tomonori Furugen; Takaharu Ichi; Kazuaki Kushi; Tomofumi Yohena; Hidenori Kawasaki; Daisuke Higuchi; Kenji Chibana; Kaori Fujita; Atsushi Nakamoto; Isoko Owan; Mutsuo Kuba; Kiyoshi Ishikawa
Journal:  Oncol Lett       Date:  2017-06-14       Impact factor: 2.967

7.  Pharmacokinetic Profile of Inhaled Submicron Particle Paclitaxel (NanoPac®) in a Rodent Model.

Authors:  James Verco; William Johnston; Michael Baltezor; Philip J Kuehl; Andrew Gigliotti; Steven A Belinsky; Anita Lopez; Ronald Wolff; Lauren Hylle; Gere diZerega
Journal:  J Aerosol Med Pulm Drug Deliv       Date:  2018-10-25       Impact factor: 2.849

8.  β-Escin alleviates cobalt chloride-induced hypoxia-mediated apoptotic resistance and invasion via ROS-dependent HIF-1α/TGF-β/MMPs in A549 cells.

Authors:  Chermakani Paneerselvam; Sudhandiran Ganapasam
Journal:  Toxicol Res (Camb)       Date:  2020-05-08       Impact factor: 3.524

9.  Tobacco smoking, NBS1 polymorphisms, and survival in lung and upper aerodigestive tract cancers with semi-Bayes adjustment for hazard ratio variation.

Authors:  Tingting Yang; Po-Yin Chang; Sungshim Lani Park; Delara Bastani; Shen-Chih Chang; Hal Morgenstern; Donald P Tashkin; Jenny T Mao; Jeanette C Papp; Jian-Yu Rao; Wendy Cozen; Thomas M Mack; Sander Greenland; Zuo-Feng Zhang
Journal:  Cancer Causes Control       Date:  2013-10-29       Impact factor: 2.506

10.  Medical renal diseases are frequent but often unrecognized in adult autopsies.

Authors:  Marie E Perrone; Anthony Chang; Kammi J Henriksen
Journal:  Mod Pathol       Date:  2017-10-06       Impact factor: 7.842

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.